AI is also capable of prioritizing studies with a higher likelihood of positive findings, ensuring the radiologist reviews these first. It can also optimize patient scheduling to maximize scanner ...
For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...